Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. S. Tam

Response to Comment On: Tam Et Al. Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps. Diabetes Care 2012;35:1605-1610

Diabetes Care

English

Comment on Lipsky Et Al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib

Haematologica

Hematology

2016

English

Related publications

Comment On: Tam Et Al. Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps. Diabetes Care 2012;35:1605-1610

English

Response to Comment On: Chang Et Al. A 25-Year Longitudinal Evaluation of Gastric Emptying in Diabetes. Diabetes Care 2012;35:2594-2596

English

Comment On: Jeffery Et Al. Age Before Stage: Insulin Resistance Rises Before the Onset of Puberty: A 9-Year Longitudinal Study (EarlyBird 26). Diabetes Care 2012;35:536-541

English

Comment On: Jeon Et Al. Helicobacter Pylori Infection Is Associated With an Increased Rate of Diabetes. Diabetes Care 2012;35:520-525

English

Response to Comment On: Chakera Et Al. Antenatal Diagnosis of Fetal Genotype Determines if Maternal Hyperglycemia Due to a Glucokinase Mutation Requires Treatment. Diabetes Care 2012;35:1832-1834

English

Response to Comment on Chong Et Al. On Diabetes Reversal in NOD Mice

Science

Multidisciplinary

Philosophy of Science

History

2006

English

Renal Denervation for Resistant Hypertension Fails to Improve Insulin Resistance as Assessed by Hyperinsulinemic-Euglycemic Step Clamp

English

Comment On: Cohen Et Al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care 2012;35:1420-1428

English

Comment on Lee Et Al. Diabetes 2015;64:2836–2846. Comment on Roberts Et Al. Diabetes 2015;64:471–484

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. S. Tam

Response to Comment On: Tam Et Al. Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps. Diabetes Care 2012;35:1605-1610

Comment on Lipsky Et Al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib

Related publications

Comment On: Tam Et Al. Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps. Diabetes Care 2012;35:1605-1610

Response to Comment On: Chang Et Al. A 25-Year Longitudinal Evaluation of Gastric Emptying in Diabetes. Diabetes Care 2012;35:2594-2596

Comment On: Jeffery Et Al. Age Before Stage: Insulin Resistance Rises Before the Onset of Puberty: A 9-Year Longitudinal Study (EarlyBird 26). Diabetes Care 2012;35:536-541

Comment On: Jeon Et Al. Helicobacter Pylori Infection Is Associated With an Increased Rate of Diabetes. Diabetes Care 2012;35:520-525

Response to Comment On: Chakera Et Al. Antenatal Diagnosis of Fetal Genotype Determines if Maternal Hyperglycemia Due to a Glucokinase Mutation Requires Treatment. Diabetes Care 2012;35:1832-1834

Response to Comment on Chong Et Al. On Diabetes Reversal in NOD Mice

Renal Denervation for Resistant Hypertension Fails to Improve Insulin Resistance as Assessed by Hyperinsulinemic-Euglycemic Step Clamp

Comment On: Cohen Et Al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care 2012;35:1420-1428

Comment on Lee Et Al. Diabetes 2015;64:2836–2846. Comment on Roberts Et Al. Diabetes 2015;64:471–484